<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03532919</url>
  </required_header>
  <id_info>
    <org_study_id>Refhina</org_study_id>
    <nct_id>NCT03532919</nct_id>
  </id_info>
  <brief_title>Heart and Renal Failure in Hip Fracture Surgery</brief_title>
  <official_title>Heart and Renal Failure in Hip Fracture Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sahlgrenska University Hospital, Sweden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sahlgrenska University Hospital, Sweden</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with acute hip fractures are old and vulnerable. With a majoriry classified as being
      ASA 3 or more. Frequently they receive spinal anesthesia perioperatively inducing
      hypotension. Even a short hypotensive period may induce postop cardiac T roponinT leakage as
      well as renal failure noted by Changes in Serum Creatinin or Cýstatin C This will be
      investigated and correlated to intraoperative hypotension as step one. Preliminary this will
      be followed by an intervention with vasopressor treatment perioperatively to preserve an
      adequte MABP
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with acute hip fractures are old and vulnerable. With a majoriry classified as being
      ASA 3 or more. Frequently they receive spinal anesthesia perioperatively inducing
      hypotension. Even a short hypotensive period may induce postop cardiac T roponinT leakage as
      awell as renal failure noted by Changes in S Creatinin or Cýstatin C This will be
      investigated and correlated to intraoperative hypotension as a step one. Preliminary this
      will be followed by an intervention with vasopressor treatment perioperatively to preserve an
      adequte MABP
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Mortality</measure>
    <time_frame>90 days</time_frame>
    <description>post surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum concentrations of Troponin, NTproBNP, Creatinin and Cystatin C</measure>
    <time_frame>90 days</time_frame>
    <description>Relations between values and mortality at 30 and 90 days</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hypotension</condition>
  <condition>Hip Fractures</condition>
  <condition>Renal Insufficiency</condition>
  <condition>Heart Injuries</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Serum Tropinin</intervention_name>
    <description>Blodsamples will be taken 4 times from preoperatively to 2 Days postoperatively</description>
    <other_name>Serum Cystatin C</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Laboratory samples on Creatinin Cystatin C NTproBNP and Troponin T
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with an acute hip fracture classified as being ASA 3 or more
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Hip fracture patient to be operated upon Classified as being ASA 3 or more

        Exclusion Criteria:

          -  Not forfilling inclusion Criterias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bengt M Nellgard, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>SahlgrenskaUniversity Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bengt M Nellgard, MD PhD</last_name>
    <phone>0046 70 6968680</phone>
    <email>bengt.nellgard@vgregion.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sahlgrenska University Hospital</name>
      <address>
        <city>Molndal</city>
        <state>Vastra Gotaland</state>
        <zip>431 80</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bengt M Nellgard, MD PhD</last_name>
      <phone>46 70 6968680</phone>
      <email>bengt.nellgard@gu.se</email>
    </contact>
    <contact_backup>
      <last_name>Per A Nellgard, MD PhD</last_name>
      <phone>46 70 328 6563</phone>
      <email>per.nellgard@vgregion.se</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2018</study_first_submitted>
  <study_first_submitted_qc>May 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2018</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sahlgrenska University Hospital, Sweden</investigator_affiliation>
    <investigator_full_name>Bengt Nellgard</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
    <mesh_term>Heart Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

